Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Feb 24, 2021. (Total: 3169 publications since 2011)
   dataset
Filtered By:
Records 1-5 (of 5 Records)
Query Trace: all>>Jesse C Thomas[CDC Author]
Sustained Transmission of Neisseria gonorrhoeae with High-Level Resistance to Azithromycin, Indianapolis, Indiana 2017-2018.
Justin L Holderman, Jesse C Thomas, Karen Schlanger, Jamie M Black, Katy Town, Sancta B Cyr, Cau D Pham, and Robert D Kirkcaldy
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Feb
Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance data.
Kim M Gernert, Sandra Seby, Matthew W Schmerer, Jesse C Thomas, Cau D Pham, Sancta St Cyr, Karen Schlanger, Hillard Weinstock, William M Shafer, Brian H Raphael, Ellen N Kersh, and
The Lancet. Microbe 2020 Aug 1(4) e154-e164
Co-occurrence of antibiotic, biocide, and heavy metal resistance genes in bacteria from metal and radionuclide contaminated soils at the Savannah River Site.
Jesse C Thomas, Adelumola Oladeinde, Troy J Kieran, John W Finger, Natalia J Bayona-Vásquez, John C Cartee, James C Beasley, John C Seaman, J Vuan McArthur, Olin E Rhodes, and Travis C Glenn
Microbial biotechnology 2020 May
Genomic characterization of Neisseria gonorrhoeae Strains from 2016 United States Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
Matthew W Schmerer, A Jeanine Abrams, Sandra Seby, Jesse C Thomas, John Cartee, Sean Lucking, Eshaw Vidyaprakash, Cau D Pham, Samera Sharpe, Kevin Pettus, Sancta B St Cyr, Elizabeth A Torrone, Ellen N Kersh, , and Kim M Gernert
Antimicrobial agents and chemotherapy 2020 Feb
Evidence of Recent Genomic Evolution in Gonococcal Strains with Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
Jesse C Thomas, Sandra Seby, A Jeanine Abrams, Jack Cartee, Sean Lucking, Eshaw Vidyaprakash, Matthew Schmerer, Cau D Pham, Jaeyoung Hong, Elizabeth Torrone, Sancta St Cyr, William M Shafer, Kyle Bernstein, Ellen N Kersh, Kim M Gernert, and
The Journal of infectious diseases 2019 Feb
TOP